| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |